Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Kuzma, Jennifer
Kuzhabekova, Aliya
and
Wilder, Kelly Morgan
2009.
Improving oversight of genetically engineered organisms.
Policy and Society,
Vol. 28,
Issue. 4,
p.
279.
Johnson, Robbin
2009.
Commentary: Emerging Technologies Oversight: Research, Regulation, and Commercialization.
Journal of Law, Medicine & Ethics,
Vol. 37,
Issue. 4,
p.
587.
Paradise, Jordan
Wolf, Susan M.
Kuzma, Jennifer
Kuzhabekova, Aliya
Tisdale, Alison W.
Kokkoli, Efrosini
and
Ramachandran, Gurumurthy
2009.
Developing U.S. Oversight Strategies for Nanobiotechnology: Learning from Past Oversight Experiences.
Journal of Law, Medicine & Ethics,
Vol. 37,
Issue. 4,
p.
688.
Nelson, Kristen C.
Andow, David A.
and
Banker, Michael J.
2009.
Problem Formulation and Option Assessment (PFOA) Linking Governance and Environmental Risk Assessment for Technologies: A Methodology for Problem Analysis of Nanotechnologies and Genetically Engineered Organisms.
Journal of Law, Medicine & Ethics,
Vol. 37,
Issue. 4,
p.
732.
Hogle, Linda F.
2009.
Science, Ethics, and the “Problems” of Governing Nanotechnologies.
Journal of Law, Medicine & Ethics,
Vol. 37,
Issue. 4,
p.
749.
Yawson, Robert M.
and
Kuzma, Jennifer
2010.
Systems Mapping of Consumer Acceptance of Agrifood Nanotechnology.
Journal of Consumer Policy,
Vol. 33,
Issue. 4,
p.
299.
Kuzma, Jennifer
and
Tanji, Todd
2010.
Unpackaging synthetic biology: Identification of oversight policy problems and options.
Regulation & Governance,
Vol. 4,
Issue. 1,
p.
92.
Kuzma, Jennifer
and
Priest, Susanna
2010.
Nanotechnology, Risk, and Oversight: Learning Lessons from Related Emerging Technologies.
Risk Analysis,
Vol. 30,
Issue. 11,
p.
1688.
Dana, David A.
2011.
The Nanotechnology Challenge.
p.
105.
Ramachandran, Gurumurthy
Wolf, Susan M.
Paradise, Jordan
Kuzma, Jennifer
Hall, Ralph
Kokkoli, Efrosini
and
Fatehi, Leili
2011.
Recommendations for oversight of nanobiotechnology: dynamic oversight for complex and convergent technology.
Journal of Nanoparticle Research,
Vol. 13,
Issue. 4,
p.
1345.
Kuzma, Jennifer
and
Kuzhabekova, Aliya
2011.
Nanotechnology, voluntary oversight, and corporate social performance: does company size matter?.
Journal of Nanoparticle Research,
Vol. 13,
Issue. 4,
p.
1499.
Meghani, Zahra
and
Kuzma, Jennifer
2011.
The “Revolving Door” between Regulatory Agencies and Industry: A Problem That Requires Reconceptualizing Objectivity.
Journal of Agricultural and Environmental Ethics,
Vol. 24,
Issue. 6,
p.
575.
Hudson, John
and
Orviska, Marta
2011.
European attitudes to gene therapy and pharmacogenetics.
Drug Discovery Today,
Vol. 16,
Issue. 19-20,
p.
843.
Kuzma, Jennifer
and
Kokotovich, Adam
2011.
Renegotiating GM crop regulation.
EMBO reports,
Vol. 12,
Issue. 9,
p.
883.
Kuzma, Jennifer
and
Kuzhabekova, Aliya
2011.
Corporate social responsibility for nanotechnology oversight.
Medicine, Health Care and Philosophy,
Vol. 14,
Issue. 4,
p.
407.
Hudson, John
2012.
Pharmacogenomics: Where does Britain Stand?.
Pharmacogenomics,
Vol. 13,
Issue. 1,
p.
1.
Gilna, Ben
Kuzma, Jennifer
and
Otts, Stephanie Showalter
2014.
Governance of genetic biocontrol technologies for invasive fish.
Biological Invasions,
Vol. 16,
Issue. 6,
p.
1299.
Mandel, Gregory N.
and
Marchant, JD, PhD, Gary E.
2014.
The Living Regulatory Challenges of Synthetic Biology.
SSRN Electronic Journal,
Kokotovich, Adam
and
Kuzma, Jennifer
2014.
Conflicting Futures.
Bulletin of Science, Technology & Society,
Vol. 34,
Issue. 3-4,
p.
108.
Antonelli, Tim
Clayton, Amanda
Hartzog, Molly
Webster, Sophia
and
Zilnik, Gabriel
2016.
Genetic Control of Malaria and Dengue.
p.
1.